Lifetime Citizen Portal Access — AI Briefings, Alerts & Unlimited Follows
Board tables Okta Pharmaceuticals’ request for an 18‑month extension; applicant asked to appear May 5
Loading...
Summary
Okta Pharmaceuticals requested an 18‑month extension to Condition 7 (time to obtain construction permits and finish construction) due to shipping delays. The applicant was not represented; the board adjourned the item to May 5 and asked the company to appear with someone able to answer questions.
Okta Pharmaceuticals asked the Bernards Township Planning Board to extend the time granted by Condition 7 of PB‑23‑001A, citing overseas sourcing and tariff‑related shipping delays that have delayed interior work. The request was submitted in a letter dated 02/26/2026 and signed by Cindy Meng, PhD, associate director HR and office for Okta.
Board members confirmed the original permit‑by date and the specifics of Condition 7; the applicant’s requested extension length was clarified as 18 months, which the board interpreted to set a new permit deadline of about Jan. 16, 2027. Because no company representative was present to answer technical or timing questions, the board agreed to adjourn the extension request to the May 5 meeting and asked Okta to have a representative — preferably an owner or someone familiar with the building and the extension request — appear with counsel if possible.
The board did not grant the extension on April 7 and deferred final action until the applicant can respond to questions in person.
